Global X S&P Biotech ETF (ASX:CURE)
Australia · Delayed Price · Currency is AUD 77.86
+1.94 (2.56%)
Sep 23, 2026, 1:52 PM AEST
ASX:CURE Holdings Information
ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Twist Bioscience stock at 1.92%, Moderna at 1.64%, Natera at 1.61%, AbbVie at 1.52%, and Halozyme Therapeutics at 1.51%.
Total Holdings
10
Top 10 Percentage
15.66%
Asset Class
Equity
ETF Category
Health Care
Assets
48.31M
PE Ratio
n/a
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TWST | Twist Bioscience Corporation | 1.92% |
| 2 | MRNA | Moderna, Inc. | 1.64% |
| 3 | NTRA | Natera, Inc. | 1.61% |
| 4 | ABBV | AbbVie Inc. | 1.52% |
| 5 | HALO | Halozyme Therapeutics, Inc. | 1.51% |
| 6 | TGTX | TG Therapeutics, Inc. | 1.50% |
| 7 | CRSP | CRISPR Therapeutics AG | 1.50% |
| 8 | SYRE | Spyre Therapeutics, Inc. | 1.50% |
| 9 | ORKA | Oruka Therapeutics, Inc. | 1.49% |
| 10 | GILD | Gilead Sciences, Inc. | 1.48% |
As of Sep 18, 2026